What does CUSIP 91307C102 represent in this 13F holders report?

CUSIP 91307C102 is the security identifier for UTHR - UNITED THERAPEUTICS Corp - Common Stock used to aggregate holder disclosures.

How many institutions held UTHR - UNITED THERAPEUTICS Corp - Common Stock in Q2 2022?

462 institutional investors reported UTHR - UNITED THERAPEUTICS Corp - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 42,833,193
Total 13F shares: 44,045,171
Share change: +386,896
Total reported value: $10,378,944,055
Put/Call ratio: 39%
Price per share: $235.64
Number of holders: 462
Value change: +$127,464,630
Number of buys: 236
Number of sells: 195

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 91307C102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	10%	4,277,089	$767,350,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	9.7%	4,168,796	$747,925,000	—	31 Mar 2022	13F
Avoro Capital Advisors LLC	13F	Company	7.1%	3,030,000	$543,612,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	6.5%	2,765,213	$496,107,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	6.3%	2,708,918	$486,007,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.9%	1,675,414	$300,585,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	3.8%	1,626,491	$291,809,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	1.9%	832,251	$149,315,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	1.7%	718,946	$128,986,000	—	31 Mar 2022	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	1.6%	664,295	$119,181,000	—	31 Mar 2022	13F
Palo Alto Investors LP	13F	Company	1.5%	653,079	$117,169,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	642,767	$115,318,000	—	31 Mar 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.5%	642,574	$115,284,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.4%	612,962	$109,962,000	—	31 Mar 2022	13F
LSV ASSET MANAGEMENT	13F	Company	1.4%	594,402	$106,642,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	583,798	$104,739,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.3%	558,232	$101,694,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	561,966	$100,814,000	—	31 Mar 2022	13F
Swedbank AB	13F	Company	0.98%	419,218	$75,211,901	—	31 Mar 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.97%	417,503	$74,904,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.97%	416,185	$74,667,751	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.91%	391,827	$70,298,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.89%	382,357	$68,599,000	—	31 Mar 2022	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.89%	379,696	$68,121,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	0.87%	373,380	$66,988,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.88%	376,391	$66,087,000	—	31 Mar 2022	13F
Epoch Investment Partners, Inc.	13F	Company	0.83%	356,939	$64,039,000	—	31 Mar 2022	13F
Polaris Capital Management, LLC	13F	Company	0.83%	354,200	$63,547,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.81%	345,576	$62,000,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.8%	342,295	$61,412,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.75%	320,459	$57,492,000	—	31 Mar 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.71%	305,850	$54,873,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.7%	300,000	$53,823,000	—	31 Mar 2022	13F
Eversept Partners, LP	13F	Company	0.68%	292,234	$52,429,702	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.64%	272,230	$48,820,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.61%	259,868	$46,624,000	—	31 Mar 2022	13F
ASSETMARK, INC	13F	Company	0.6%	257,331	$46,168,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.55%	233,524	$41,897,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.54%	232,531	$41,718,000	—	31 Mar 2022	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.54%	232,027	$41,627,000	—	31 Mar 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.49%	209,917	$37,661,000	—	31 Mar 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.49%	209,556	$37,596,000	—	31 Mar 2022	13F
EMERALD ADVISERS, LLC	13F	Company	0.47%	203,359	$36,485,000	—	31 Mar 2022	13F
Krensavage Asset Management, LLC	13F	Company	0.47%	201,612	$36,171,000	—	31 Mar 2022	13F
Sofinnova Investments, Inc.	13F	Company	0.47%	199,183	$35,735,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.46%	197,100	$35,362,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.46%	195,507	$35,077,000	—	31 Mar 2022	13F
Iron Triangle Partners LP	13F	Company	0.44%	190,073	$34,101,000	—	31 Mar 2022	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.42%	179,478	$32,200,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.42%	178,269	$31,983,000	—	31 Mar 2022	13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2022

As of 30 Jun 2022, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 462 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,045,171 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, Avidity Partners Management LP, and JANUS HENDERSON GROUP PLC. This page lists 463 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

416

Q2 2022 holders

462

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.